Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 5851-5900 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT07103096
Infiltration in Rheumatology With 3D Virtual Reality Headset Pilot Study for the Evaluation of Satisfaction (ICARE)
N/ARecruiting
30 participants
Started: May 28, 2025 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT07124546
Acceptance and Commitment Therapy (ACT-HBC) for the Improvement of Cancer Distress in Patients With Hepatobiliary Cancers
NARecruiting
60 participants
Started: May 28, 2025 · Completed: May 30, 2027
1 condition1 sponsor1 location
NCT07121660
Post-operative Changes Study
N/ARecruiting
17 participants
Started: May 28, 2025 · Completed: May 31, 2027
2 conditions3 sponsors1 location
NCT07009405
Assessment Intravenous Site Events During Outpatient Infusion Procedures With a Wireless Thermal Measurement Device During
NARecruiting
10 participants
Started: May 28, 2025 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06884592
Determination of the Frequency and Predictors of Difficult Intubation in Septoplasty Operations
N/ARecruiting
300 participants
Started: May 28, 2025 · Completed: May 30, 2026
5 conditions1 sponsor1 location
NCT06782373
A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)
PHASE2Recruiting
78 participants
Started: May 28, 2025 · Completed: Aug 31, 2027
2 conditions2 sponsors40 locations
NCT06931405
Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)
PHASE2Recruiting
105 participants
Started: May 28, 2025 · Completed: Dec 31, 2026
2 conditions1 sponsor32 locations
NCT06942936
A Study to Investigate the Impact of Multiple Doses of Itraconazole on AZD5004 in Healthy Participants and Multiple Doses of AZD5004 on Combined Oral Ethinyl Oestradiol and Levonorgestrel in Healthy Female Participants
PHASE1Recruiting
50 participants
Started: May 28, 2025 · Completed: Feb 6, 2026
1 condition2 sponsors2 locations
NCT06160284
Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)
PHASE1Recruiting
12 participants
Started: May 28, 2025 · Completed: Jan 31, 2027
1 condition2 sponsors1 location
NCT06592924
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
PHASE3Recruiting
830 participants
Started: May 28, 2025 · Completed: Apr 15, 2031
1 condition5 sponsors1 location
NCT06603363
Changes in Plaque Characteristics After Short-term Statin Therapy as Assessed With Coronary CT
NARecruiting
140 participants
Started: May 28, 2025 · Completed: Dec 15, 2028
10 conditions3 sponsors1 location
NCT06785064
Optimizing an Extended Care Intervention to Promote Weight Loss Maintenance
NARecruiting
544 participants
Started: May 28, 2025 · Completed: Feb 28, 2029
4 conditions2 sponsors1 location
NCT06912984
Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men
NARecruiting
242 participants
Started: May 28, 2025 · Completed: Jul 31, 2029
3 conditions2 sponsors1 location
NCT06357299
Assessing Better Bottles for Babies
NARecruiting
76 participants
Started: May 28, 2025 · Completed: May 1, 2026
3 conditions2 sponsors1 location
NCT06995144
Comparing Natriuretic Effects of ER Torsemide to IR Torsemide in Patients With Heart Failure
PHASE4Recruiting
20 participants
Started: May 28, 2025 · Completed: Mar 15, 2026
4 conditions1 sponsor1 location
NCT06971640
Advancing Identification of Circadian Delay in ADHD Youth: Associations With Clinical Heterogeneity and Cognition
N/ARecruiting
250 participants
Started: May 28, 2025 · Completed: Nov 30, 2029
2 conditions2 sponsors1 location
NCT06976268
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
PHASE2/PHASE3Recruiting
550 participants
Started: May 28, 2025 · Completed: Sep 30, 2027
1 condition1 sponsor65 locations
NCT06682988
A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine
PHASE2Recruiting
110 participants
Started: May 28, 2025 · Completed: Mar 31, 2028
5 conditions1 sponsor15 locations
NCT06666322
Platform Trial For Cryptococcal Meningitis
PHASE2/PHASE3Recruiting
2,000 participants
Started: May 28, 2025 · Completed: Apr 21, 2032
2 conditions1 sponsor2 locations
NCT06564623
Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC)
PHASE1Recruiting
25 participants
Started: May 27, 2025 · Completed: May 31, 2029
1 condition3 sponsors1 location
NCT06937307
Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury
PHASE2Recruiting
75 participants
Started: May 27, 2025 · Completed: Dec 31, 2027
3 conditions1 sponsor1 location
NCT06420375
Treatment of UC With Novel Therapeutics
PHASE2Recruiting
20 participants
Started: May 27, 2025 · Completed: Jul 31, 2027
2 conditions1 sponsor1 location
NCT06757647
Acalabrutinib for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
PHASE2Recruiting
61 participants
Started: May 27, 2025 · Completed: Dec 31, 2027
1 condition3 sponsors1 location
NCT06945107
A Study of Switching to Picankibart in Chinese Patients With Plaque Psoriasis With an Inadequate Response to Interleukin-17 Monoclonal Antibody Therapy
PHASE3Recruiting
310 participants
Started: May 27, 2025 · Completed: Jan 19, 2027
1 condition1 sponsor1 location
NCT06932757
Adjuvant Quisinostat in High-Risk Uveal Melanoma
PHASE2Recruiting
63 participants
Started: May 27, 2025 · Completed: May 27, 2030
1 condition3 sponsors1 location
NCT06088953
EARLY DETECTION OF DEAFNESS IN A MEMORY CENTER
NARecruiting
200 participants
Started: May 27, 2025 · Completed: Aug 27, 2027
2 conditions1 sponsor1 location
NCT07062770
Assessment of Circuit Rebreathing During CPAP Therapy
NARecruiting
13 participants
Started: May 27, 2025 · Completed: Dec 1, 2025
1 condition2 sponsors1 location
NCT06870812
Rapid Evacuation and Access of Cerebral Hemorrhage Trial
NARecruiting
600 participants
Started: May 27, 2025 · Completed: Mar 31, 2030
1 condition2 sponsors3 locations
NCT07062744
The Role of Swan-Ganz Catheter in Hemodynamic Resuscitation for Patients With Cardiogenic Shock
NARecruiting
108 participants
Started: May 27, 2025 · Completed: Dec 30, 2027
9 conditions2 sponsors1 location
NCT06782932
Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer
PHASE1/PHASE2Recruiting
38 participants
Started: May 27, 2025 · Completed: Dec 31, 2028
1 condition4 sponsors1 location
NCT07059572
Comparative Evaluation of Guava Leaf Extract and Chlorhexidine Mouthwash in Patients With Chronic Gingivitis
NARecruiting
160 participants
Started: May 27, 2025 · Completed: Oct 30, 2025
1 condition1 sponsor1 location
NCT06954584
Fluzoparib+Bevacizumab/Dietary Intervention vs Fluzoparib Monotherapy as First-line Maintenance in HRD+/- Advanced Ovarian Cancer
PHASE3Recruiting
424 participants
Started: May 27, 2025 · Completed: Mar 1, 2032
1 condition1 sponsor2 locations
NCT07021560
Wearability of and Myopia Progression With ZEISS MyoCare Spectacle Lenses
NARecruiting
90 participants
Started: May 27, 2025 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT06873334
Study of SKY-0515 for Safety, Efficacy, and Pharmacodynamics in Participants With Huntington's Disease
PHASE2/PHASE3Recruiting
120 participants
Started: May 27, 2025 · Completed: Dec 31, 2027
2 conditions1 sponsor10 locations
NCT06536166
Ruxolitinib Treatment in Inclusion Body Myositis
PHASE2Recruiting
80 participants
Started: May 27, 2025 · Completed: Sep 10, 2028
1 condition1 sponsor16 locations
NCT07012395
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
PHASE2Recruiting
645 participants
Started: May 27, 2025 · Completed: Mar 31, 2028
4 conditions1 sponsor49 locations
NCT06980428
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels
PHASE1Recruiting
120 participants
Started: May 27, 2025 · Completed: Dec 4, 2026
1 condition1 sponsor5 locations
NCT06810713
Evaluation of a Training for Healthcare Providers in Supporting Men Experiencing Suicidal Ideation
NARecruiting
120 participants
Started: May 27, 2025 · Completed: Dec 15, 2025
2 conditions1 sponsor1 location
NCT06130826
Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer
PHASE1Recruiting
24 participants
Started: May 27, 2025 · Completed: Sep 5, 2026
2 conditions2 sponsors1 location
NCT06615908
Treatment of Persistent Post-concussive Symptoms With Psilocybin Assisted Therapy
PHASE1Recruiting
40 participants
Started: May 27, 2025 · Completed: Mar 30, 2027
1 condition2 sponsors1 location
NCT06323954
tVNS During Motor Training in Older Adults
NARecruiting
32 participants
Started: May 27, 2025 · Completed: Jul 31, 2026
1 condition2 sponsors1 location
NCT06908460
Training of Nursing Home Professionals and Quality of Life of Residents With Parkinson's Disease
N/ARecruiting
90 participants
Started: May 27, 2025 · Completed: Aug 26, 2027
1 condition2 sponsors1 location
NCT06395285
Evaluating the Safety and Tolerability of Orally Administered DF-003 in ROSAH Syndrome Patients
PHASE1Recruiting
12 participants
Started: May 27, 2025 · Completed: May 31, 2026
1 condition1 sponsor4 locations
NCT06992778
Effectiveness and Acceptability of Remote Fine-Tuning of Hearing Aids in Danish Adults
NARecruiting
120 participants
Started: May 27, 2025 · Completed: Mar 30, 2026
4 conditions2 sponsors1 location
NCT07009288
A Study of Time-Restricted Eating in Childhood Cancer Survivors
NARecruiting
300 participants
Started: May 27, 2025 · Completed: May 1, 2031
1 condition1 sponsor4 locations
NCT07032584
Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer
NARecruiting
74 participants
Started: May 27, 2025 · Completed: Dec 31, 2029
3 conditions3 sponsors1 location
NCT07047209
Trial of Oral Digoxin in Individuals With Amyotrophic Lateral Sclerosis (ALS)
PHASE2Recruiting
40 participants
Started: May 27, 2025 · Completed: Apr 30, 2026
1 condition1 sponsor3 locations
NCT06978660
Multicenter Study for the Validation of an AI-based ECG Platform for Early Cardiac Amyloidosis Diagnosis
N/ARecruiting
500 participants
Started: May 27, 2025 · Completed: Oct 31, 2025
1 condition2 sponsors6 locations
NCT06981195
Effects of Lemborexant on Insomnia and Its Relationship to Mood and Behavior on Opioid Use Disorder Subjects
PHASE2Recruiting
100 participants
Started: May 27, 2025 · Completed: Jul 30, 2029
4 conditions2 sponsors1 location
NCT06410131
Study in Patients With Advanced Solid Tumors to Evaluate the Safety of FTL008.16
PHASE1Recruiting
68 participants
Started: May 27, 2025 · Completed: Nov 30, 2027
1 condition1 sponsor1 location